8-K

Company

Elicio Therapeutics, Inc.

Filed

July 25, 2022

Period of Report

July 25, 2022

Accession Number

0001601485-22-000061

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →